2025
Linking attention bias to youth social anxiety and depression: Insights from computational modeling of the affective Posner task
Edgar E, Castagna P, Delpech R, Crowley M. Linking attention bias to youth social anxiety and depression: Insights from computational modeling of the affective Posner task. Journal Of Affective Disorders 2025, 388: 119764. PMID: 40562109, PMCID: PMC12282653, DOI: 10.1016/j.jad.2025.119764.Peer-Reviewed Original ResearchDepressive symptom severityParent-reported social anxietyAttentional biasSocial anxietySymptom severityPubertal statusFunction of pubertal statusThreat-related stimuliDrift diffusion model parametersSymptoms of psychopathologyYouth social anxietyLatent cognitive processesSymptoms of anxietyDrift diffusion parametersHigher pubertal statusPosner taskDepressive symptomatologyPredicting anxietyDepressive symptomsCognitive processesEvidence accumulationDrift rateAnxietyDepressionBehavioral dataMental Health, Substance Use, and Tuberculosis Preventive Therapy in People With HIV: A Prospective Cohort Study
Johnson A, Chimoyi L, Shenoi S, Brault M, Forastiere L, Charalambous S, Chihota V, Davis J. Mental Health, Substance Use, and Tuberculosis Preventive Therapy in People With HIV: A Prospective Cohort Study. Open Forum Infectious Diseases 2025, 12: ofaf303. PMID: 40567997, PMCID: PMC12188208, DOI: 10.1093/ofid/ofaf303.Peer-Reviewed Original ResearchTuberculosis preventive therapyUnhealthy alcohol useMental healthDepressive symptomsAlcohol useTobacco useAssociation of mental healthInfluence of mental healthCohort studyMeasure symptoms of anxietyNegatively associated with adherenceDeductive content analysisMixed methods studySubstance useLongitudinal cohort studyPsychological support servicesSymptoms of anxietySymptoms of depressionPreventive therapyProspective cohort studyAntiretroviral therapyHIV mortalityMultivariate regression modelSubstance use disordersMethods studyMusic mindfulness acutely modulates autonomic activity and improves psychological state in anxiety and depression
Ramirez C, Alayine G, Akafia C, Adichie K, Watts D, Galdamez Y, Harding L, Allsop A. Music mindfulness acutely modulates autonomic activity and improves psychological state in anxiety and depression. Frontiers In Neuroscience 2025, 19: 1554156. PMID: 40264912, PMCID: PMC12013341, DOI: 10.3389/fnins.2025.1554156.Peer-Reviewed Original ResearchMusical mindSymptoms of anxietyMindfulness sessionsMusic listeningMusicImproved psychological stateHeart rate variabilityModerate symptoms of anxietyPsychological stateStates of consciousnessParticipants’ psychological statesMindfulnessSelf-reported sexDepressive symptomsLive sessionsStress managementMeasures of heart rate variabilitySocial connectionsIncreased HRVReduce stressEEG power spectral densityPsychological effectsAnxietyDepressionParticipantsTrajectories of depression and anxiety in adults with rare disorders across 13 months during the COVID-19 pandemic
Halsøy Ø, Orm S, Cogo-Moreira H, Silverman W, Fjermestad K. Trajectories of depression and anxiety in adults with rare disorders across 13 months during the COVID-19 pandemic. Orphanet Journal Of Rare Diseases 2025, 20: 138. PMID: 40114232, PMCID: PMC11924719, DOI: 10.1186/s13023-025-03633-3.Peer-Reviewed Original ResearchConceptsMental healthTrajectories of mental health symptomsMeasure symptoms of anxietyMultiple psychosocial risk factorsHealth care appointmentsSymptoms of anxietyPsychosocial risk factorsMental health symptomsTrajectories of depressionMental health problemsCOVID-19 pandemicMulti-level growth curve modelRisk factorsGrowth curve modelsLevels of anxietyCoronavirus Anxiety ScaleImpaired quality of lifeQuality of lifeCare appointmentsLack of longitudinal dataChecklist-5Depressive symptomsHealth symptomsAnxiety ScaleCOVID fearA Retrospective Analysis of the Impact of Electroconvulsive Therapy on Anxiety Symptoms in Patients With Treatment-Resistant Depression.
Laszcz J, Wang C, Riva-Posse P, Kim J, Tsygankova V, Mandell A, Rice H, Hermida A, Kitay B, Crowell A, McDonald W, Hershenberg R. A Retrospective Analysis of the Impact of Electroconvulsive Therapy on Anxiety Symptoms in Patients With Treatment-Resistant Depression. Journal Of Ect 2025 PMID: 39853314, DOI: 10.1097/yct.0000000000001113.Peer-Reviewed Original ResearchTreatment-resistant depressionTreatment-resistant depressed patientsElectroconvulsive therapySymptoms of depressionSymptoms of anxietyAnxiety symptomsDepressive symptomsAcute course of ECTGeneralized Anxiety Disorder 7 scalePredictors of antidepressant responseImprovement of anxiety symptomsImpact of electroconvulsive therapyCourse of ECTImprove symptoms of anxietyHigher symptoms of anxietyBeck Depression Inventory IIAnxiety symptom severityNaturalistic outpatient settingAcute ECT courseHigher levels of anxietyElectroconvulsive therapy treatmentsLevels of anxietyTrajectory of improvementAntidepressant responseAnxious symptomsLiving From Test to Test: A Concept Analysis of CA-125 Preoccupation in Ovarian Cancer Survivorship
Gormley M, Dunnack Yackel H, Redeker N. Living From Test to Test: A Concept Analysis of CA-125 Preoccupation in Ovarian Cancer Survivorship. Cancer Care Research Online 2025, 5: e064. DOI: 10.1097/cr9.0000000000000064.Peer-Reviewed Original ResearchPsychosocial symptomsImprove survivorship careCINAHL electronic databasesEvolutionary concept analysisConcept analysisSymptoms of anxietySurvivorship careCancer survivorshipCare preferencesIllness intrusivenessPatient experienceCA-125 levelsCA-125Diagnosis of ovarian cancerElectronic databasesOvarian cancerHigh riskSurvey measuresHigh risk of recurrencePrompt actionDisease statusRisk of recurrenceAnxietySymptomsNurses
2024
Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
Craiglow B, Lee Y, Vañó-Galván S, Egeberg A, Dutronc Y, Durand F, Pierce E, Yu G, Chen Y, Mostaghimi A. Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib. Dermatology And Therapy 2024, 14: 1959-1968. PMID: 38904749, PMCID: PMC11265044, DOI: 10.1007/s13555-024-01208-x.Peer-Reviewed Original ResearchSymptoms of anxietyQuality of lifeDomain scoresHealth-related quality of lifeMeasures of quality of lifeMeasures of HRQOLHealth-related qualityBaricitinib 2 mgSALT scoreBaricitinib 4 mgPsychosocial distressAssociated with improvementsHair regrowthAA scaleMethodsThis post hoc analysisHRQoLDose of baricitinibInterquartile rangePhase III trialsResultsIn totalSevere alopecia areataPost Hoc AnalysisDisease associated with high ratesDepressionScoresPriorities for HIV and chronic pain research: results from a survey of individuals with lived experience
Robinson-Papp J, Lawrence S, Wadley A, Scott W, George M, Josh J, O’Brien K, Price C, Uebelacker L, Edelman E, Evangeli M, Goodin B, Harding R, Nkhoma K, Parker R, Sabin C, Slawek D, Tsui J, Merlin J. Priorities for HIV and chronic pain research: results from a survey of individuals with lived experience. AIDS Care 2024, 36: 1291-1301. PMID: 38588701, PMCID: PMC11458822, DOI: 10.1080/09540121.2024.2334358.Peer-Reviewed Original ResearchChronic painOptimal management of painSocial health factorsExperience of HIVSymptoms of anxietyManagement of painWeb-based surveyChronic pain researchMultisite painSurvey of individualsHealth factorsPain treatmentTreatment cost-effectivenessUS-based respondentsTask ForceGlobal Task ForceResearch prioritiesSurvey responsesPain researchMedian numberPainHIVOptimal managementTreatment individualizationAddiction treatmentStigma and Anxiety and Depressive Symptoms in Parents of Sexual and Gender Minority Youth
Clark K, Argiros A, Dougherty L, Pachankis J. Stigma and Anxiety and Depressive Symptoms in Parents of Sexual and Gender Minority Youth. Journal Of Family Psychology 2024, 38: 201-211. PMID: 38227468, PMCID: PMC10922310, DOI: 10.1037/fam0001183.Peer-Reviewed Original ResearchConceptsSGM youthVicarious stigmaStigma experiencesDepressive symptomsPatient-Reported Outcomes Measurement Information System short formsSelf-reported anxietyAssessed parents' experiencesSymptoms of anxietyConsequences of stigmaChild mental healthMental health difficultiesCross-sectional studySGM childrenGender minoritiesSGM peopleStigma measuresExperience stigmaYouths' parentsHealth difficultiesMental healthAnxietyInvestigate associationsSGMStigmaEmotional consequencesHealth care access, psychosocial outcomes and mental health in adults living with epilepsy during the COVID-19 pandemic
Mc Carthy L, Mathew B, Blank L, Van Hyfte G, Gotlieb E, Goldstein J, Agarwal P, Kwon C, Singh A, Fields M, Marcuse L, Yoo J, Sivarak E, Gururangan K, Navis A, Jetté N. Health care access, psychosocial outcomes and mental health in adults living with epilepsy during the COVID-19 pandemic. Epilepsy & Behavior 2024, 151: 109617. PMID: 38219607, DOI: 10.1016/j.yebeh.2023.109617.Peer-Reviewed Original ResearchConceptsPatient Health Questionnaire-9Generalized Anxiety Disorder-7Psychosocial outcomesMental healthHealthcare accessCancelled visitsCross-sectional study of adultsHealth care accessCOVID-19 pandemicMental health comorbiditiesPoor mental healthSocial support issuesPoor psychosocial outcomesSymptoms of anxietyCross-sectional studyStudy of adultsCare accessPsychosocial supportHealth comorbiditiesModerate/severe depressionHealth systemTelehealth visitsNeurological carePLWEStandardized questionnaire
2023
Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
Piraccini B, Ohyama M, Craiglow B, Bewley A, Ding Y, Chen Y, Dutronc Y, Pierce E, Durand F, Mostaghimi A. Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials. JEADV Clinical Practice 2023, 3: 242-248. DOI: 10.1002/jvc2.269.Peer-Reviewed Original ResearchSevere alopecia areataSymptoms of anxietyHealth-related qualityAlopecia areataWeek 36Hair regrowthAutoimmune hair loss disorderPsychological burdenBackground Alopecia areataProportion of patientsPhase 3 trialSelective Janus kinase 1JAK-2 inhibitorHair loss disorderBaricitinib 2Nonresponder imputationMethods PatientsHADS scoresMore patientsLarge trialsHospital AnxietyDepression ScaleAA symptomsPsychosocial distressAnalysis of covarianceQuality of Life in Emicizumab-Treated People with Hemophilia A in the ATHN 7 Hemophilia Natural History Study - an Assessment of Baseline PROMIS®-29 Scores
Buckner T, Daoud N, Lee L, Lim E, Schwartz J, Raimundo K, Recht M. Quality of Life in Emicizumab-Treated People with Hemophilia A in the ATHN 7 Hemophilia Natural History Study - an Assessment of Baseline PROMIS®-29 Scores. Blood 2023, 142: 3998. DOI: 10.1182/blood-2023-174092.Peer-Reviewed Original ResearchImpairment of physical functionPain interferencePhysical functionPROMIS-29Reference population meanQuality of lifePatient-Reported Outcomes Measurement Information SystemReference populationOutcomes Measurement Information SystemT-scoreHealth-related quality of lifeCohort studyPatient-reported outcome measuresStudy entrySocial health domainsMeasurement Information SystemPROMIS-29 profileT-score metricUS reference populationHealth-related qualityUS general populationSleep disturbanceSymptoms of anxietyProspective observational cohort studyPROMIS measuresEfficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trial
Skov O, Johansen J, Nielsen J, Larroudé C, Riahi S, Melchior T, Vinther M, Skovbakke S, Rottmann N, Wiil U, Brandt C, Smolderen K, Spertus J, Pedersen S. Efficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trial. EP Europace 2023, 25: euad253. PMID: 38055845, PMCID: PMC10700011, DOI: 10.1093/europace/euad253.Peer-Reviewed Original ResearchConceptsWeb-based interventionUsual careDevice acceptanceFlorida Patient Acceptance SurveySymptoms of anxietyCare of patientsSymptoms of depressionQuality of lifeImplantable cardioverter defibrillatorImplantable cardioverter defibrillator patientsRandomized Controlled TrialsFirst-time ICD recipientsOnline patient forumsRemote device monitoringImplant centresPsychological interventionsHealthcare innovationAcceptability surveyStandard interventionGoal settingAnxiety symptomsPatient forumsCareInterventionNon-blindedAssociation of marital/partner status and patient-reported outcomes following myocardial infarction: a systematic review and meta-analysis
Zhu C, Tran P, Leifheit E, Spatz E, Dreyer R, Nyhan K, Wang S, Lichtman J. Association of marital/partner status and patient-reported outcomes following myocardial infarction: a systematic review and meta-analysis. European Heart Journal Open 2023, 3: oead018. PMID: 36942107, PMCID: PMC10023828, DOI: 10.1093/ehjopen/oead018.Peer-Reviewed Original ResearchPatient-reported outcome measuresMarital/partner statusPersonal recovery outcomesMyocardial infarctionHigher HRQoLMI patientsPartner statusSystematic reviewOutcome domainsRecovery outcomesSex differencesPatient-reported outcomesNewcastle-Ottawa ScaleStandardized mean differenceSymptoms of anxietyPotential sex differencesUnpartnered patientsFunctional statusSubgroup analysisEligible studiesStudy qualityOutcome measuresPeer-reviewed studiesMean differencePatientsMaternal FGF2 levels associated with child anxiety and depression symptoms through child FGF2 levels
Lebowitz E, Marin C, Orbach M, Salmaso N, Vaccarino F, Silverman W. Maternal FGF2 levels associated with child anxiety and depression symptoms through child FGF2 levels. Journal Of Affective Disorders 2023, 326: 193-197. PMID: 36717031, PMCID: PMC10104478, DOI: 10.1016/j.jad.2023.01.090.Peer-Reviewed Original ResearchConceptsFGF2 levelsDepressive symptomsDepression symptomsChild anxietySymptoms of anxietyRatings of anxietyGrowth factor 2Maternal anxietySymptomsDepressed childrenDepressionChild depressionMothersChildrenFactor 2Self-report ratingsAnxietyIntergenerational pathwaysNon-referred childrenRange of anxietyFGF2AssociationLevelsMaternalThe DIAMOND-KID: Psychometric Properties of a Structured Diagnostic Interview for DSM-5 Anxiety, Mood, and Obsessive-Compulsive and Related Disorders in Children and Adolescents
Tolin D, Sain K, Davis E, Gilliam C, Hannan S, Springer K, Stubbing J, George J, Jean A, Goldblum R, Katz B, Everhardt K, Darrow S, Ohr E, Young M, Serchuk M. The DIAMOND-KID: Psychometric Properties of a Structured Diagnostic Interview for DSM-5 Anxiety, Mood, and Obsessive-Compulsive and Related Disorders in Children and Adolescents. Assessment 2023, 30: 2351-2363. PMID: 36632642, DOI: 10.1177/10731911221143994.Peer-Reviewed Original ResearchConceptsSelf-report measuresDiagnostic InterviewSemi-structured diagnostic interviewObsessive-compulsive disorderGeneralized anxiety disorderSymptoms of anxietyDSM-5 AnxietyPediatric psychiatric disordersTest-retest reliability dataDisorder childrenAdolescent versionTest-retest reliabilityObsessive-CompulsiveAnxiety disordersConvergent validitySemi-structured interviewsQuestionable rangePsychometric propertiesAnxietyMoodRelated disordersInterrater reliability dataInitial interviewParents/guardiansGroup comparisons
2022
The Initial Response to COVID-19 Disruptions for Older People with HIV in Ukraine
Rozanova J, Rich K, Altice F, Shenoi S, Zaviryukha I, Kiriazova T, Mamedova E, Shipunov O, Yariy V, Deac A, Zeziulin O. The Initial Response to COVID-19 Disruptions for Older People with HIV in Ukraine. Geriatrics 2022, 7: 138. PMID: 36547274, PMCID: PMC9777936, DOI: 10.3390/geriatrics7060138.Peer-Reviewed Original ResearchGeneralised anxiety disorderSymptoms of depressionSymptoms of anxietyHIV treatmentSevere depressionOlder peopleMental healthActive drug useSubstance use disordersFirth logistic regression modelHigher suicidal ideationLogistic regression modelsIndependent correlatesUse disordersTelehealth strategiesDrug useSuicidal ideationSymptomsHIVAnxiety disordersSubstance useDepressionStandardised scalesCOVID-19 restrictionsInitial responseCoping, symptoms, and insomnia among people with heart failure during the COVID-19 pandemic
O’Connell M, Jeon S, Conley S, Linsky S, Redeker NS. Coping, symptoms, and insomnia among people with heart failure during the COVID-19 pandemic. European Journal Of Cardiovascular Nursing 2022, 22: 291-298. PMID: 35938348, PMCID: PMC9384676, DOI: 10.1093/eurjcn/zvac072.Peer-Reviewed Original ResearchConceptsSleep-related cognitionsCognitive behavioral therapySleep characteristicsPandemic-related stressPandemic-related stressorsSymptoms of anxietyInvoluntary engagementInvoluntary disengagementBehavioral therapyStressful eventsSleep problemsInsomnia severityMood disturbanceCopingCOVID-19 pandemicSecondary controlAnxietyCognitionParticipantsDaytime symptomsHeart failureInsomniaDepressionPeopleCBTLearning to Record Your Experiences
Pachankis J, Jackson S, Harkness A, Safren S. Learning to Record Your Experiences. 2022, 23-32. DOI: 10.1093/med-psych/9780197643341.003.0003.Peer-Reviewed Original ResearchSocial media use and mental health during the COVID-19 pandemic in young adults: a meta-analysis of 14 cross-sectional studies
Lee Y, Jeon Y, Kang S, Shin J, Jung Y, Jung S. Social media use and mental health during the COVID-19 pandemic in young adults: a meta-analysis of 14 cross-sectional studies. BMC Public Health 2022, 22: 995. PMID: 35581597, PMCID: PMC9112239, DOI: 10.1186/s12889-022-13409-0.Peer-Reviewed Original ResearchConceptsMental health outcomesHealth outcomesOdds ratioRisk of bias assessment toolAssociated with depressive symptomsMental health needsAssociated with anxiety symptomsMeasure mental health symptomsMental health symptomsMeta-analysisBias assessment toolSymptoms of anxietyCross-sectional studyRandom-effects modelHealth needsMeta-analysis reviewQuality assessmentSocial media platformCOVID-19 quarantineMental healthHealth symptomsInter-study heterogeneityDepressive symptomsSocial media platformsAnxiety symptoms
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply